VC  Evidity Health Capital

https://www.evidity.com/





     Office Locations:

1111 Brickell Ave, Suite 1525
Miami, FL 33131
Phone: 305-371-4578

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Evidity Health Capital (formerly known as Canepa Healthcare) is a late-stage venture and growth capital firm specializing in medical devices, in vitro diagnostics, and disruptive digital health. The firm focuses on private companies with commercialized products that need growth capital to achieve profitability. Evidity seeks out healthcare companies with products in the growth stage that have achieved regulatory clearance in the United States or Europe. The firm is interested in companies needing at least $5 million of new capital. Evidity focuses on medical devices and diagnostics but does not restrict itself to specific sub-sectors.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Adam Lessler MD Principal
    Alejandro Sanchez Managing Director
    Lilly Shahidi Associate
    Paul Enever PhD Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/28/2023


      Augmedics


      IL


      $82,500,000


      Series D


     

    Portfolio companies include:


      Akili Interactive Labs
        web link


      Augmedics
        web link


      Bio Theranostics


      Dune Medical Devices


      EndoGastric Solutions


      Magnolia Medical


      Prelude Dx


      Sonde


      Standard Molecular


     

    Recent News: